Windtree Therapeutics Inc /De/ (WINTW) SEC Filings — 2024

Filings

• Windtree Therapeutics Faces Delisting Concerns — 8-K · Dec 5, 2024
• Windtree Therapeutics Files 8-K — 8-K · Dec 4, 2024
• Windtree Therapeutics Files 8-K on Financials and Delisting Concerns — 8-K · Nov 27, 2024
• Windtree Therapeutics Q3 2024: Net Loss Continues — 10-Q · Nov 26, 2024
• Windtree Therapeutics Files 8-K/A Amendment on Leadership Changes — 8-K/A · Nov 15, 2024
• Windtree Therapeutics Board Changes and Officer Compensation — 8-K · Nov 14, 2024
• Windtree Therapeutics Inc /De/ SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Windtree Therapeutics Inc /De/ SC 13G Filing — SC 13G · Nov 14, 2024
• Windtree Therapeutics Inc /De/ SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Windtree Therapeutics Files 8-K — 8-K · Oct 28, 2024
• Windtree Therapeutics Files 8-K — 8-K · Oct 4, 2024
• Windtree Therapeutics Files 8-K — 8-K · Oct 1, 2024
• Windtree Therapeutics Files 8-K — 8-K · Sep 30, 2024
• Windtree Therapeutics Files 8-K — 8-K · Sep 25, 2024
• Windtree Therapeutics Submits Matters to Security Holders — 8-K · Sep 24, 2024
• Windtree Therapeutics to be Acquired by Cerus Corporation Affiliate — 8-K · Sep 13, 2024
• Windtree Therapeutics Files 2024 Proxy Statement — DEF 14A · Sep 3, 2024
• Windtree Therapeutics Files S-1 for Securities Registration — S-1 · Aug 23, 2024
• Windtree Therapeutics Files 8-K on Financials — 8-K · Aug 20, 2024
• Windtree Therapeutics Q2 2024: Net Loss of $33.1M — 10-Q · Aug 19, 2024
• Windtree Therapeutics Appoints New Chief Medical Officer — 8-K · Aug 14, 2024
• Windtree Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Jul 29, 2024
• Windtree Therapeutics Announces Material Agreements and Equity Changes — 8-K · Jul 22, 2024
• Windtree Therapeutics Secures $30M Loan Facility — 8-K · Jul 10, 2024
• Windtree Therapeutics Files 8-K Report — 8-K · Jul 3, 2024
• Windtree Therapeutics Files 8-K on Agreements and Equity Sales — 8-K · Jul 1, 2024
• Windtree Therapeutics Files 10-Q for Q1 2024 — 10-Q · May 15, 2024
• Windtree Therapeutics Files S-1 Registration Statement — S-1 · May 9, 2024
• Windtree Therapeutics Files 8-K Report — 8-K · Apr 23, 2024
• Windtree Therapeutics Files 8-K on Security Holder Rights — 8-K · Apr 19, 2024
• Windtree Therapeutics Files 8-K Report — 8-K · Apr 17, 2024
• Windtree Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Apr 16, 2024
• Windtree Therapeutics Files 8-K on Security Holder Vote Matters — 8-K · Apr 10, 2024
• Windtree Therapeutics Secures Series A Funding — 8-K · Apr 8, 2024
• Windtree Therapeutics to Hold Special Meeting for Reverse Stock Split Approval — DEF 14A · Mar 12, 2024
• Windtree Therapeutics Reports Executive Changes and Compensation Updates — 8-K · Feb 16, 2024
• Windtree Therapeutics Inc /De/ SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Lind Global Fund II Exits Windtree Therapeutics Stake — SC 13G/A · Feb 13, 2024
• Deerfield Management Discloses Significant Stake in Windtree Therapeutics — SC 13G · Feb 1, 2024
• Windtree Therapeutics Files Routine 8-K; No New Material Info — 8-K · Jan 31, 2024
• Windtree Therapeutics Sells Unregistered Equity, Raises Capital — 8-K · Jan 25, 2024
• Windtree Therapeutics Faces Delisting Notice — 8-K · Jan 22, 2024
• Windtree Therapeutics Enters Material Definitive Agreement — 8-K · Jan 17, 2024